Informed-money record

WVE · Wave Life Sciences Ltd.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

7

Bearish filings

79

Named actors

29

Disclosed $ (bull / bear)

$82.6M / $32.4M

Recent disclosures

25 of 86 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-03-30Director RA CAPITAL MANAGEMENT, L.P.bought$6.3MSEC ↗
2026-03-27Director RA CAPITAL MANAGEMENT, L.P.bought$16.0MSEC ↗
2026-03-26Director RA CAPITAL MANAGEMENT, L.P.bought$30.0MSEC ↗
2026-03-26Director RA CAPITAL MANAGEMENT, L.P.bought$2.2MSEC ↗
2026-03-11a member of our board of directors Gregory Verdineadopted a selling planSEC ↗
2026-03-06a member of our board of directors Adrian Rawcliffeadopted a selling planSEC ↗
2026-03-06a member of our board of directors Heidi Wagneradopted a selling planSEC ↗
2026-03-06a member of our board of directors Mark Corriganadopted a selling planSEC ↗
2026-02-26See Remarks Francis Chrissold$229KSEC ↗
2026-02-26See Remarks Francis Chrissold$270KSEC ↗
2026-02-09Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) PAUL BOLNOfiled notice to sell$140KSEC ↗
2026-02-09Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) Chris Francisfiled notice to sell$25KSEC ↗
2026-02-09Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) KYLE MORANfiled notice to sell$48KSEC ↗
2026-02-09See Remarks Vargeese Chandrasold$43KSEC ↗
2026-02-09See Remarks Francis Chrissold$25KSEC ↗
2026-02-09President and CEO BOLNO PAULsold$141KSEC ↗
2026-02-09Chief Financial Officer Moran Kylesold$48KSEC ↗
2026-01-02See Remarks Francis Chrissold$22KSEC ↗
2026-01-02See Remarks Francis Chrissold$129KSEC ↗
2025-12-18Mr. Moranadopted a selling planSEC ↗
2025-12-17Dr. Vargeeseadopted a selling planSEC ↗
2025-12-16Chief Technology Officer Chandra Vargeeseterminated a selling planSEC ↗
2025-12-1110% owner / other GSK plcbought$27.9MSEC ↗
2025-12-09Chief Financial Officer Moran Kylesold$729SEC ↗
2025-12-09Chief Financial Officer Moran Kylesold$1.0MSEC ↗

61 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals